In vivo evaluation of neutron capture therapy effectivity using calcium phosphate-based nanoparticles as Gd-DTPA delivery agent.

Identification of Suitable Reference Genes for Normalization of Real-Time Quantitative Polymerase Chain Reaction in an Intestinal Graft-Versus-Host Disease Mouse Model.

AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis.

Metabolic reprogramming of cancer-associated fibroblasts by IDH3α downregulation.

Expression patterns of dishevelled-2 in different colon tissue segments in Hirschsprung's disease.

MicroRNA-195 chemosensitizes colon cancer cells to the chemotherapeutic drug doxorubicin by targeting the first binding site of BCL2L2 mRNA.

Apple polysaccharide reduces NF-Kb mediated colitis-associated colon carcinogenesis.

Activating and propagating polyclonal gamma delta T cells with broad specificity for malignancies.

Polymeric micelles loaded with platinum anticancer drugs target preangiogenic micrometastatic niches associated with inflammation.

Chlorogenic acid decreases intestinal permeability and increases expression of intestinal tight junction proteins in weaned rats challenged with LPS.

Comparative study of Hsp27, GSK3β, Wnt1 and PRDX3 in Hirschsprung's disease.

Study of the effect of miR‑124 and the SOX9 target gene in Hirschsprung's disease.

Differential expressions of BMPR1α, ACTN4α and FABP7 in Hirschsprung disease.

WNT3A gene expression is associated with isolated Hirschsprung disease polymorphism and disease status.

Expression analysis of BMP2, BMP5, BMP10 in human colon tissues from Hirschsprung disease patients.